Date: Tuesday 08 Sep 2009
Catalogue-based antibodies distributor Abcam underlined the recession-proof nature of its business with doubled profits in the year just ended.
The AIM-listed group made £16.3m in the year to June, against £8m last time, on revenues up by 55.2% to £56.8m (2008: £36.6m) and by 27.8% on a constant...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news